I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology
EXHIBIT 1: COVID-19 Vaccines in Pipeline by Technology
Synthetic Biologists Create Slow-Growing Version of COVID-19 as
Vaccine Candidate
Role of Synthetic Biology in Combating COVID-19
Synthetic Biology: A Prelude
Growing Importance of Synthetic Biology
Applications of Synthetic Biology
Synthetic Biology Tools
Technologies Involved
Market Outlook
Regional Landscape
Major Challenges and Concerns
Teeming R&D Funding & Potential to Alter Molecular Landscape
Enable Global Synthetic Biology Market to Remain in High
Spirits
Competitive Landscape
Major Players by Industry Verticals
Synthetic Biology Startups Get Aggressive on Bioengineered
Product Commercialization
Compelling Breakthroughs Drive Funding
Top Funded Synthetic Biology Startups in Q2 2020
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Synthetic Biology Market Witnesses Significant Rise in Investments
Importance of Synthetic Biology for Investments
Efforts from Leading Players Bodes Well for Market Growth
Patent Landscape Gets Richer
Synthetic Biology Patent Landscape by Assignee Countries (in %)
: 2003-2018
Top 15 Patent Assignees in Synthetic Biology Domain: 2003-2018
Select Patent Assignees for Synthetic Biology in the US: 2019
Robotics and Workflow Automation Support Market Expansion
Advancements in Instrumentation Augurs Well
Improvements in Computer-Aided Biology
Fusion of AI and Synthetic Biology Expands Opportunities
Synthetic Biology Brings a Paradigm Shift in the Field of
Biological Research
DNA Sequencing Plays an Important Role
Plummeting Cost of DNA Sequencing Bolsters Market Growth
EXHIBIT 2: Cost per Genome Sequencing: 2001-2020
Food Scarcity to Fuel Synthetic Biology Application in Agriculture
Select Companies Engaged in Making Food Using Synthetic Biology
Synthetic Biology Aids in Development of Exotic and
Artificially Grown Meats and Proteins to Meet Future Food
Demand
Growing Demand for GM Crops Opens Up Growth Avenues
Synthetic Biology-based Ingredients Gain Traction
Role of Synthetic Biology in Producing Plants with Desirable
Characteristics
Synthetic Biology Gains Prominence in Biomedical Applications
Synthetic Genes Open up a New World of Drug Development
Synthetic Biology to Transform Healthcare with Captivating
Advances in Biomedicine
Synthetic Biology Enables Creation of Advanced Biosensing Systems
Synthetic Biology Gains Significance in Production of Bio-Based
Chemicals and Biofuels
EXHIBIT 3: Global Biofuels Market in US$ Billion: 2019 and 2024
Synthetic Biology Gains Importance as Focus on Carbon Recycling
Increases
Synthetic Biology Disrupts the Cosmetics Sector
Capability of Synthetic Biology in Environmental Applications
Synthetic Biology Creates Buzz as Key Enabler of Exciting &
Dynamic Applications for Diverse Domains
Synthetic Biology for Advanced, Multifunctional Materials
Genetically Engineered Fabrics and Sustainable Dyes Using
Synthetic Biology to Transform Textile Industry
EXHIBIT 4: Select Synthetic Biology Offerings in Textile Industry

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Synthetic Biology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Synthetic Biology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 3: World 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2015, 2020 & 2027

Table 4: World Current & Future Analysis for Oligonucleotides &
Synthetic DNA by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Oligonucleotides & Synthetic
DNA by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 6: World 12-Year Perspective for Oligonucleotides &
Synthetic DNA by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2020 & 2027

Table 7: World Current & Future Analysis for Enzymes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Enzymes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 9: World 12-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2015, 2020 & 2027

Table 10: World Current & Future Analysis for Cloning
Technology Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Cloning Technology Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 12: World 12-Year Perspective for Cloning Technology Kits
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 13: World Current & Future Analysis for Synthetic Cells
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Synthetic Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 15: World 12-Year Perspective for Synthetic Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 16: World Current & Future Analysis for Xeno-Nucleic
Acids (XNA) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Xeno-Nucleic Acids (XNA) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 18: World 12-Year Perspective for Xeno-Nucleic Acids
(XNA) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2015, 2020 & 2027

Table 19: World Current & Future Analysis for Chassis Organism
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Chassis Organism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 21: World 12-Year Perspective for Chassis Organism by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 22: World Current & Future Analysis for Nucleotide
Synthesis & Sequencing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Nucleotide Synthesis &
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 24: World 12-Year Perspective for Nucleotide Synthesis &
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2015, 2020 & 2027

Table 25: World Current & Future Analysis for Genome
Engineering by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 26: World Historic Review for Genome Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 27: World 12-Year Perspective for Genome Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 28: World Current & Future Analysis for Microfluidics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Microfluidics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 30: World 12-Year Perspective for Microfluidics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 31: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 33: World 12-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 34: World Current & Future Analysis for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 36: World 12-Year Perspective for Pharmaceuticals &
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2020 & 2027

Table 37: World Current & Future Analysis for Industrial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 38: World Historic Review for Industrial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 39: World 12-Year Perspective for Industrial by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 40: World Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 41: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 42: World 12-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 43: World Current & Future Analysis for Environmental by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 44: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 45: World 12-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

Table 46: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 47: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 48: World 12-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 49: USA Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 51: USA 12-Year Perspective for Synthetic Biology by Tool -
Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 52: USA Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: USA Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 54: USA 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027

Table 55: USA Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: USA Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 57: USA 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027

CANADA
Table 58: Canada Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 59: Canada Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 60: Canada 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 61: Canada Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Canada Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 63: Canada 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027

Table 64: Canada Current & Future Analysis for Synthetic
Biology by Application - Pharmaceuticals & Diagnostics,
Industrial, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Canada Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 66: Canada 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027

JAPAN
Table 67: Japan Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 69: Japan 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 70: Japan Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: Japan Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 72: Japan 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027

Table 73: Japan Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Japan Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 75: Japan 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027

CHINA
Table 76: China Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: China Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 78: China 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 79: China Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 80: China Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 81: China 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027

Table 82: China Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: China Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 84: China 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027

EUROPE
Table 85: Europe Current & Future Analysis for Synthetic
Biology by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 87: Europe 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2015, 2020 & 2027

Table 88: Europe Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: Europe Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 90: Europe 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 91: Europe Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Europe Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 93: Europe 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027

Table 94: Europe Current & Future Analysis for Synthetic
Biology by Application - Pharmaceuticals & Diagnostics,
Industrial, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Europe Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 96: Europe 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027

FRANCE
Table 97: France Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 98: France Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 99: France 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027

Table 100: France Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Ot